The upregulation of IP-10, p53, and Foxp3 expression was 19.32-, 2.61-, and 14.48-fold in HBV-positive HCC patients when compared with HBV-negative HCC patients (1.00-, 1.00-, and 1.00-fold; not shown). Here, TP53 is linked to hepatocellular carcinoma.